Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hib meningococcal vaccine groups A and C conjugate - Jiangsu Provincial Center for Disease Control and Prevention/Wuxi Royal Biological

Next Previous
Search
Drug Profile

Hib meningococcal vaccine groups A and C conjugate - Jiangsu Provincial Center for Disease Control and Prevention/Wuxi Royal Biological

Alternative Names: A+C+hib Conjugate Vaccine; Group A, C polysaccharide meningococcal and type b haemophilus Influenzal Conjugate vaccine; Hib-MenAC; MenAC-Hib; Meninogococcal vaccine groups A and C Hib conjugate

Latest Information Update: 31 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jiangsu Provincial Center for Disease Control and Prevention
  • Developer Jiangsu Provincial Center for Disease Control and Prevention; Wuxi Royal Biological
  • Class Conjugate vaccines; Haemophilus vaccines; Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Haemophilus infections; Meningococcal group A infections; Meningococcal group C infections

Most Recent Events

  • 15 Oct 2018 No recent reports on development identified- phase III for Haemophilus infections (In children, In infants, Prevention) in China (IM)
  • 15 Oct 2018 No recent reports on development identified- phase III for Meningococcal group A infections (In children, In infants, Prevention) in China (IM)
  • 15 Oct 2018 No recent reports on development identified- phase III for Meningococcal group C infections (In children, In infants, Prevention) in China (IM)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top